Complex Coronary Valvular and Vascular Cases Conference

Can Coronary Artery Disease Be Eliminated In Our Lifetime?

By Complex Coronary Valvular and Vascular Cases Conference
11/2017
2 Comments
Login to view comments. Click here to Login

Featured Video

15:44
Radius Health

Postmenopausal Osteoporosis in Women at High Risk for Fracture: A Sequen...

Feat. F. Cosman

Related Content

AUTOPLAY
Scripps Health - Primary Care

36th Annual Primary Care Summer Conference

Fri, Aug 9, 2019
Cardiometabolic Health Congress (CMHC)

14th Annual Cardiometabolic Health Congress (CMHC)

Thu, Oct 10, 2019
Didactic Presentations

Diabetes Updates

Fri, Sep 20, 2019
16:56
William White

Ambulatory Blood Pressure Monitoring

12:38
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

11:09
Craig Beavers

PCSK9 Inhibitors: Pharmacology, Indications, Drug Interactions, Dosing L...

28:16
American Society of Nuclear Cardiology

Women with Suspected Ischemic Heart Disease: What is the Best Diagnostic...

Feat. J. Mieres
21:10
National Lipid Association

Plant-based Diets for Improving Lipids

Feat. K. Williams
12:11
Peter Howard Jones

Clinical Trials with PCSK9 Inhibitors and Lipid Efficacy

10:49
Northwestern Medicine Cardiovascular Care

Clyde W. Yancy, MD and Neil J. Stone, MD Discuss New Cardiovascular Guid...

Feat. C. Yancy, N. Stone
23:04
Craig Beavers

HIV Heart-Attack: Optimizing Your HIV Patient Post Acute Coronary Syndrome

25:22
Cardiometabolic Health Congress (CMHC)

Non-Statin Drugs and New Approaches

Feat. M. Sabatine, C. Ballantyne
17:40
Cardiovascular Disease Management - 4th Annual Symposium

Can We Cure Arteriosclerosis? New Thoughts and Concepts and New Game Cha...

25:41
National Lipid Association

Cardiodiabetology: Optimizing ASCVD Risk Reduction

Feat. N. Wong
20:06
National Lipid Association

Comparison 2013 and 2018 Cholesterol Guidelines in Secondary Prevention

Feat. C. Orringer
25:47
ASPC 2018 Congress on CVD Prevention

PCSK9 Inhibitors Today - When, How, and In Whom

Feat. J. Robinson
17:23
National Lipid Association

ACC/AHA Cholesterol Guideline: How to Handle the High-Risk Patients

Feat. K. Birtcher
16:12
ASPC 2018 Congress on CVD Prevention

Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Hi...

Feat. P. Moriarty
19:57
National Lipid Association

Results of REDUCE-IT

Feat. M. Miller
10:17
Cleveland Clinic Heart and Vascular Institute

Results of the GLAGOV Trial: Global Assessment of Plaque Regression With...

Feat. S. Nissen
41:33
National Lipid Association

New Drugs in Development for Dyslipidemia

3:4
Cleveland Clinic Heart and Vascular Institute

PCSK9 News from ACC: Recap of FOURIER, EBBINGHAUS substudy, SPIRE & ORION-1

Feat. S. Nissen
22:35
National Lipid Association

What Should the Clinical Lipidologist Do with The REDUCE-IT Results?

Feat. P. Jones